FR2187327B1 - - Google Patents
Info
- Publication number
- FR2187327B1 FR2187327B1 FR7221607A FR7221607A FR2187327B1 FR 2187327 B1 FR2187327 B1 FR 2187327B1 FR 7221607 A FR7221607 A FR 7221607A FR 7221607 A FR7221607 A FR 7221607A FR 2187327 B1 FR2187327 B1 FR 2187327B1
- Authority
- FR
- France
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/32—Sulfur atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Vascular Medicine (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Rheumatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Priority Applications (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7221607A FR2187327B1 (US20100012521A1-20100121-C00001.png) | 1972-06-15 | 1972-06-15 | |
| ES415277A ES415277A1 (es) | 1972-06-15 | 1973-05-28 | Procedimiento de preparacion de derivados de la cisterna. |
| CA173,160A CA1019745A (en) | 1972-06-15 | 1973-06-04 | Process for preparing cysteine derivatives |
| ZA733812A ZA733812B (en) | 1972-06-15 | 1973-06-05 | Cysteine derivatives |
| GB2729173A GB1389814A (en) | 1972-06-15 | 1973-06-07 | Cysteine derivatives and production thereof |
| US05/367,821 US3950387A (en) | 1972-06-15 | 1973-06-07 | Cysteine derivatives |
| JP48066246A JPS5239815B2 (US20100012521A1-20100121-C00001.png) | 1972-06-15 | 1973-06-11 | |
| AU56772/73A AU490997B2 (en) | 1972-06-15 | 1973-06-12 | Cysteine derivatives |
| DE19732329819 DE2329819C3 (de) | 1972-06-15 | 1973-06-12 | S-Substituierte-L-Cysteine und Verfahren zu ihrer Herstellung |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7221607A FR2187327B1 (US20100012521A1-20100121-C00001.png) | 1972-06-15 | 1972-06-15 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2187327A1 FR2187327A1 (US20100012521A1-20100121-C00001.png) | 1974-01-18 |
| FR2187327B1 true FR2187327B1 (US20100012521A1-20100121-C00001.png) | 1975-06-20 |
Family
ID=9100257
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR7221607A Expired FR2187327B1 (US20100012521A1-20100121-C00001.png) | 1972-06-15 | 1972-06-15 |
Country Status (7)
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4002634A (en) * | 1969-09-04 | 1977-01-11 | Societe Anonyme Dite: L'oreal | N-oxypyridyl substituted cysteine or cysteine derivative thereof |
| US4105789A (en) * | 1976-05-10 | 1978-08-08 | E. R. Squibb & Sons, Inc. | Carboxyalkylacylamino acids |
| US4160835A (en) * | 1976-11-19 | 1979-07-10 | Merck & Co., Inc. | Antihypertensive compositions containing an arylsubstituted alanine and a phenyl hydrazinopropionic acid |
| US4093739A (en) * | 1977-06-15 | 1978-06-06 | Mead Johnson & Company | Mercaptoacylamidobenzoyl glycine and mucolytic process |
| ES469060A1 (es) * | 1978-04-22 | 1979-04-01 | Invest Tecnica Aplicada | Procedimiento para la preparacion de nuevos derivados tio- prenilicos con actividad farmacologica |
| LU83327A1 (fr) * | 1981-04-29 | 1983-03-24 | Midit | Procede de preparation de derives de 1,4-thiazine,leur utilisation ainsi que compositions contenant ces derives |
| US4571430A (en) * | 1982-11-08 | 1986-02-18 | Medi-Physics, Inc. | Homocysteine and homocysteinamide derivatives |
| US6030950A (en) * | 1987-07-09 | 2000-02-29 | Ohlenschlaeger; Gerhard | Pharmaceutical therapeutic use of glutathione derivative |
| GB2217706A (en) * | 1988-07-07 | 1989-11-01 | W A Gibbons | alpha -Amino-alkanoic acid derivatives and process for their preparation with anti-inflammatory, analgesic, sedative, hypnotic, anxiolytic, spasmolytic, anaesthetic, muscle relaxant and cardiovascular activity |
| US5464825A (en) * | 1991-03-14 | 1995-11-07 | Cornell Research Foundation, Inc. | Raising glutathione equivalent levels using N-acyl glutathione monoesters |
| TW225992B (US20100012521A1-20100121-C00001.png) * | 1992-07-17 | 1994-07-01 | Senju Pharma Co | |
| WO1994025052A1 (en) * | 1993-05-03 | 1994-11-10 | Cornell Research Foundation, Inc. | Use of glutathione diesters |
| JP4255138B2 (ja) * | 1996-05-24 | 2009-04-15 | 湧永製薬株式会社 | 脳疾患治療剤 |
| US6492429B1 (en) * | 2000-07-10 | 2002-12-10 | N.V. Nutricia | Composition for the treatment of osteoarthritis |
| US6384078B1 (en) * | 2000-11-21 | 2002-05-07 | Arthur Vanmoor | Method of treating elevated cholesterol levels by enhancing the effectiveness of the human immune system |
| US8765817B1 (en) | 2008-12-03 | 2014-07-01 | Arrowhead Center, Inc. | Selective inhibitors of EG5 motors and methods of use |
| US8349899B1 (en) | 2008-12-03 | 2013-01-08 | Arrowhead Center, Inc. | Selective inhibitors of EG5 motors and methods of use |
| JP2013035772A (ja) * | 2011-08-05 | 2013-02-21 | Osaka City Univ | 白血球活性化抑制剤 |
| KR101511056B1 (ko) * | 2013-06-28 | 2015-04-10 | 한밭대학교 산학협력단 | 신규한 ｓ-알릴 시스테인 유도체 및 그의 용도 |
| WO2017096450A1 (en) * | 2015-12-07 | 2017-06-15 | Ems S/A | New compounds with antioxidant and antiaging activity |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3531490A (en) * | 1968-09-06 | 1970-09-29 | Us Agriculture | S-beta-(4-pyridylethyl)-l-cysteine |
-
1972
- 1972-06-15 FR FR7221607A patent/FR2187327B1/fr not_active Expired
-
1973
- 1973-05-28 ES ES415277A patent/ES415277A1/es not_active Expired
- 1973-06-04 CA CA173,160A patent/CA1019745A/en not_active Expired
- 1973-06-05 ZA ZA733812A patent/ZA733812B/xx unknown
- 1973-06-07 US US05/367,821 patent/US3950387A/en not_active Expired - Lifetime
- 1973-06-07 GB GB2729173A patent/GB1389814A/en not_active Expired
- 1973-06-11 JP JP48066246A patent/JPS5239815B2/ja not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| DE2329819B2 (de) | 1977-04-07 |
| CA1019745A (en) | 1977-10-25 |
| FR2187327A1 (US20100012521A1-20100121-C00001.png) | 1974-01-18 |
| AU5677273A (en) | 1974-12-12 |
| ES415277A1 (es) | 1976-02-01 |
| JPS5239815B2 (US20100012521A1-20100121-C00001.png) | 1977-10-07 |
| JPS504020A (US20100012521A1-20100121-C00001.png) | 1975-01-16 |
| DE2329819A1 (de) | 1974-01-03 |
| GB1389814A (en) | 1975-04-09 |
| US3950387A (en) | 1976-04-13 |
| ZA733812B (en) | 1974-04-24 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| TP | Transmission of property | ||
| ST | Notification of lapse |